Literature DB >> 55418

Fractionation of cells on a discontinuous Ficoll gradient. Study of subpopulations of human T cells using anti-T-cell antibodies from patients with systemic lupus erythematosus.

W Glinski, M E Gershwin, A D Steinberg.   

Abstract

Patients with active systemic lupus erythematosus (SLE) had a decrease in a subpopulation of cells (fraction D) when peripheral blood lymphocytes were separated on a discontinuous Ficoll gradient. Preincubation of SLE cells at 37 degrees C for 30 min led to a marked decrease in this fraction, composed primarily of thymus-derived (T) cells. Supernates of such preincubations were found to cause a reduction in fraction D cells from normal humans. The active factor in the supernate was found to be an IgG antibody. Similarly, serum from patients with active SLE produced a reduction in fraction D cells from normal donors. This activity was also found in the IgG fraction, and could be absorbed with a pure T-cell population. Depletion of macrophages and complement did not reduce the SLE anti-T-cell antibody-mediated loss of cells from fraction D; however, heat-aggregated human gamma globulin led to impairment of the reaction. These findings suggest that antibody-dependent direct lymphocyte-mediated cytotoxicity may play a role in T-cell lymphopenia of SLE. It was further noted that the SLE anti-T-cell antibodies, in contrast to rabbit antihuman thymocyte serum, recognized fraction D cells but not fraction E cells from normals. Since both fractions are largely T cells, it appeared that the SLE serum was directed against cell-membrane antigenic determinants present on fraction D T cells, which were absent or reduced in quantity on fraction E T cells. Thus, evidence was presented indicating the presence of at least two subpopulations of cells in man. This was supported by differential absorption of the anti-T-cell sera with fractions D and E.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55418      PMCID: PMC436693          DOI: 10.1172/JCI108316

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Reversible restoration by thymosin of antigen-induced depression of spleen DNA synthesis in NZB mice.

Authors:  M J Dauphinee; N Talal
Journal:  J Immunol       Date:  1975-06       Impact factor: 5.422

2.  Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases.

Authors:  A M HARVEY; L E SHULMAN; P A TUMULTY; C L CONLEY; E H SCHOENRICH
Journal:  Medicine (Baltimore)       Date:  1954-12       Impact factor: 1.889

3.  Dose-dependent hyporreactivity to phytohemagglutinin in systemic lupus erythematosus.

Authors:  I Malavé; Z Layrisse; M Layrisse
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

4.  Suppression of autoimmune hemolytic anemia in New Zealand (NZB) mice by syngeneic young thymocytes.

Authors:  M E Gershwin; A D Steinberg
Journal:  Clin Immunol Immunopathol       Date:  1975-05

5.  Impaired delayed hypersensitivity in systemic lupus erythematosus.

Authors:  D A Horwitz
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

6.  Lymphocyte cytotoxic antibodies in systemic lupus erythematosus.

Authors:  K K Mittal; R D Rossen; J T Sharp; M D Lidsky; W T Butler
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

7.  Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics.

Authors:  R P Messner; M S Kennedy; J G Jelinek
Journal:  Arthritis Rheum       Date:  1975 May-Jun

8.  Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity.

Authors:  C J Rosenthal; E C Franklin
Journal:  Arthritis Rheum       Date:  1975 May-Jun

9.  Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus.

Authors:  J Schneider; W Chin; G J Friou; S M Cooper; B Harding; R L Hill; F P Quismorio
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

10.  Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes.

Authors:  P Stastny; M Ziff
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

View more
  25 in total

1.  Effect of ageing on surface IgG of human peripheral lymphocytes.

Authors:  C Zanussi; C Rugarli; B Perussia; R S Smeraldi
Journal:  Experientia       Date:  1977-06-15

2.  Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

3.  A serum inhibitor of immune regulation in patients with systemic lupus erythematosus.

Authors:  J J Twomey; A H Laughter; A D Steinberg
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

Review 4.  Antibodies to CD45 and other cell membrane antigens in systemic lupus erythematosus.

Authors:  J B Winfield; P Fernsten; J Czyzyk; E Wang; J Marchalonis
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  [The significance of Fc-IgG and Fc-IgM receptors on human T-lymphocytes (author's transl)].

Authors:  W J Pichler
Journal:  Klin Wochenschr       Date:  1981-02-02

6.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Suppressor-cell antibody in systemic lupus erythematosus. Possible mechanism for suppressor-cell dysfunction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

Review 8.  Lymphocytotoxic antibodies in SLE: a review of the literature.

Authors:  C Osman; A J Swaak
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

9.  Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.

Authors:  S Kumagai; A D Steinberg; I Green
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

10.  Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions.

Authors:  C Morimoto; E L Reinherz; J A Distaso; A D Steinberg; S F Schlossman
Journal:  J Clin Invest       Date:  1984-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.